Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Monday, July 7, 2008

DARPA gives $3.2M for Textron laser weapons

By Mass High Tech Staff


Textron Defense Systems has landed a $3.2 million payment from the U.S. Defense Advanced Research Projects Agency for work on a laser weapons system, according to the U.S. Department of Defense.

Wilmington-based Textron Defense Systems — a unit of Textron Inc. (NYSE: TXT) — will do the work as part of the High Energy Liquid Laser Area Defense System, a DARPA project intended to develop a high-energy laser weapon small enough to be used on U.S. military aircraft.

The payment is for Phase 2 of an earlier $21.3 million deal from DARPA. Work on the contract will be performed in Wilmington, Cambridge and Charlestown, as well as Virginia, Missouri and New Mexico.  
 
Last year, Textron acquired United Industrial Corp., a Maryland company that made unmanned aircraft systems, aviation ground support systems and armored vehicles for the defense and aerospace industries, for $1.1 billion.

Providence-based Textron reported a 2007 net income of $917 million on revenue of $13.2 billion.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.